Sleep: Clinical Trials

11 trials for Sleep, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 11
Phase 23Completed 3

Follow Sleep: new trials by email Literature Review of Sleep trials Research Report on Sleep

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
KETONE-IQ 20 grams (g), KETONE-IQ 40 grams (g) - Healthy Participants, Sleep
Phase 1CompletedJohns Hopkins University202025-12-182026-09-28
Nurse-Led Elderly Sleep Intervention
Otago programme, Otago programme + Cognifit, Control - Sleep, Gerontology
Phase 1 / Phase 2CompletedUniversity of Castilla-La Mancha662025-09-012026-05-22
Impact of Nutritional Supplementation on Sleep Quality
Sleep Supplements, Placebo - Sleep, Sleep Quality
Phase 1CompletedPharmavite LLC3762025-05-152026-02-27
Consciousness, Psilocybin, and Well-Being
Psilocybin, Clonidine, Saline - Healthy, Psychedelic Experiences
Phase 1CompletedUniversity of Wisconsin, Madison62023-11-072025-05-16
Remote-delivered MBCT for SCAD Survivors
MBCT - Acute Coronary Syndrome, Coronary Artery Disease
Phase 1CompletedMassachusetts General Hospital192021-11-042024-09-19
Can Ammonium Inhalants Maintain Performance in Sleep Deprived Soldiers?
Ammonia Inhalant - Sleep Deprivation, Military Activity
Phase 1CompletedJan Malecek182020-10-012023-05-22
Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep
Rest-ZZZ, Active Comparator - Diphenhydramine HCl, Placebo - Sleep, Healthy
Phase 1CompletedLifeSeasons Inc.272019-09-242021-03-02
A Personalized Behavioral Intervention to Improve Physical Activity, Sleep and Cognition in Sedentary Older Adults
ELDERFITNESS, Control - Sleep
Phase 1 / Phase 2CompletedJohns Hopkins University1292019-07-112023-03-08
Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic
Dexmedetomidine, Saline Placebo - Sleep, Insomnia
Phase 1 / Phase 2CompletedMassachusetts General Hospital152016-10-012019-10-02
Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers
PF-04457845 / matched placebo - Healthy, Sleep
Phase 1CompletedPfizer302010-04-012018-12-04
Bright Light: A Novel Treatment for Anxiety
Litebook Bright Light Box, Litebook inactivated negation ion generator (the placebo) - Anxiety, Depression
Phase 1CompletedUniversity of South Carolina332006-10-012021-04-28

Narrower conditions

Anxiety Disorders (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Acute Coronary Syndrome (1)  ·  Coronary Artery Disease (1)  ·  Depression (1)  ·  Ketosis (1)  ·  Motor Activity (1)  ·  Sleep Deprivation (1)

Broader conditions

Mental Disorders (5)  ·  Dyssomnias (3)  ·  Nervous System Diseases (3)  ·  Sleep Wake Disorders (3)  ·  Behavior (2)  ·  Sleep Disorders, Intrinsic (2)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Behavioral Symptoms (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Metabolic Diseases (1)

Interventions

Sodium Chloride (2)  ·  Ammonia (1)  ·  Clonidine (1)  ·  Dexmedetomidine (1)  ·  N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide (1)  ·  Phototherapy (1)  ·  Psilocybin (1)

Sponsors

Johns Hopkins University (2)  ·  Massachusetts General Hospital (2)  ·  Jan Malecek (1)  ·  LifeSeasons Inc. (1)  ·  Pfizer (1)  ·  Pharmavite LLC (1)  ·  University of Castilla-La Mancha (1)  ·  University of South Carolina (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (8)  ·  Canada (1)  ·  Czechia (1)  ·  Spain (1)

Top investigators

Charles Raison, MD (1)  ·  Christina M Luberto, PhD (1)  ·  David Crowley, MD (1)  ·  Jan Malecek (1)  ·  Jonathan Jun, MD (1)  ·  Junxin Li, PhD (1)  ·  Shawn D Youngstedt (1)

Results publications

PMID 21254315, PMID 41120129, PMID 41925207

NIH funding

P30AG064198 (1), R00NR016484 (1)